News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
599,868 Results
Type
Article (43056)
Company Profile (317)
Press Release (556495)
Multimedia
Podcasts (72)
Webinars (11)
Section
Business (167590)
Career Advice (2448)
Deals (30313)
Drug Delivery (108)
Drug Development (78742)
Employer Resources (149)
FDA (14440)
Job Trends (13014)
News (295982)
Policy (28545)
Tag
Academia (2677)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (87)
Alliances (42956)
ALS (104)
Alzheimer's disease (1455)
Antibody-drug conjugate (ADC) (151)
Approvals (14422)
Artificial intelligence (273)
Autoimmune disease (27)
Automation (17)
Bankruptcy (326)
Best Places to Work (10699)
BIOSECURE Act (16)
Biosimilars (97)
Biotechnology (258)
Bladder cancer (87)
Brain cancer (29)
Breast cancer (297)
Cancer (2366)
Cardiovascular disease (199)
Career advice (2059)
Career pathing (32)
CAR-T (168)
Cell therapy (463)
Cervical cancer (19)
Clinical research (63990)
Collaboration (861)
Company closure (2)
Compensation (417)
Complete response letters (25)
COVID-19 (2571)
CRISPR (49)
C-suite (273)
Cystic fibrosis (104)
Data (2358)
Decentralized trials (2)
Denatured (15)
Depression (54)
Diabetes (273)
Diagnostics (5847)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (40)
Drug discovery (126)
Drug pricing (111)
Drug shortages (22)
Duchenne muscular dystrophy (104)
Earnings (62291)
Editorial (42)
Employer branding (21)
Employer resources (136)
Events (90203)
Executive appointments (769)
FDA (15786)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (767)
Gene editing (119)
Generative AI (22)
Gene therapy (354)
GLP-1 (756)
Government (4273)
Grass and pollen (5)
Guidances (165)
Healthcare (17270)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (147)
Indications (30)
Infectious disease (2720)
Inflammatory bowel disease (154)
Inflation Reduction Act (12)
Influenza (54)
Intellectual property (101)
Interviews (525)
IPO (14273)
IRA (45)
Job creations (2742)
Job search strategy (1684)
Kidney cancer (11)
Labor market (25)
Layoffs (469)
Leadership (23)
Legal (6057)
Liver cancer (77)
Lung cancer (338)
Lymphoma (153)
Machine learning (9)
Management (52)
Manufacturing (308)
MASH (86)
Medical device (11140)
Medtech (11144)
Mergers & acquisitions (16593)
Metabolic disorders (735)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (112)
Neuropsychiatric disorders (34)
Neuroscience (2059)
NextGen: Class of 2025 (5975)
Non-profit (4118)
Now hiring (36)
Obesity (381)
Opinion (236)
Ovarian cancer (82)
Pain (95)
Pancreatic cancer (88)
Parkinson's disease (163)
Partnered (21)
Patents (243)
Patient recruitment (115)
Peanut (47)
People (54127)
Pharmaceutical (55)
Pharmacy benefit managers (16)
Phase I (20103)
Phase II (28276)
Phase III (21037)
Pipeline (1434)
Policy (152)
Postmarket research (2390)
Preclinical (8528)
Press Release (60)
Prostate cancer (110)
Psychedelics (37)
Radiopharmaceuticals (258)
Rare diseases (418)
Real estate (4484)
Recruiting (60)
Regulatory (20384)
Reports (27)
Research institute (2277)
Resumes & cover letters (360)
Rett syndrome (6)
RNA editing (6)
RSV (40)
Schizophrenia (80)
Series A (133)
Series B (93)
Service/supplier (3)
Sickle cell disease (56)
Special edition (15)
Spinal muscular atrophy (153)
Sponsored (28)
Startups (3174)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (42)
The Weekly (56)
Vaccines (678)
Venture capitalists (41)
Weight loss (256)
Women's health (27)
Worklife (17)
Date
Today (211)
Last 7 days (901)
Last 30 days (3206)
Last 365 days (30998)
2025 (11657)
2024 (33526)
2023 (37471)
2022 (48408)
2021 (52018)
2020 (49977)
2019 (42539)
2018 (32084)
2017 (29605)
2016 (28150)
2015 (32900)
2014 (25341)
2013 (20525)
2012 (21738)
2011 (22667)
2010 (20372)
Location
Africa (742)
Alabama (55)
Alaska (4)
Arizona (171)
Arkansas (13)
Asia (36430)
Australia (7234)
California (6066)
Canada (1995)
China (524)
Colorado (260)
Connecticut (249)
Delaware (159)
Europe (81832)
Florida (898)
Georgia (194)
Idaho (55)
Illinois (502)
India (24)
Indiana (286)
Iowa (8)
Japan (172)
Kansas (96)
Kentucky (22)
Louisiana (11)
Maine (52)
Maryland (882)
Massachusetts (4481)
Michigan (209)
Minnesota (359)
Mississippi (2)
Missouri (80)
Montana (24)
Nebraska (22)
Nevada (62)
New Hampshire (66)
New Jersey (1716)
New Mexico (25)
New York (1705)
North Carolina (951)
North Dakota (6)
Northern California (2639)
Ohio (184)
Oklahoma (11)
Oregon (33)
Pennsylvania (1289)
Puerto Rico (13)
Rhode Island (30)
South America (1018)
South Carolina (23)
South Dakota (1)
Southern California (2333)
Tennessee (95)
Texas (883)
United States (22493)
Utah (178)
Virginia (143)
Washington D.C. (58)
Washington State (538)
West Virginia (3)
Wisconsin (51)
599,868 Results for "tarveda therapeutics fomerly known as blend therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress
May 12, 2025
·
7 min read
Press Releases
Ascidian Therapeutics Announces Formation of Scientific Advisory Board
May 6, 2025
·
5 min read
Press Releases
HLS Therapeutics partners with Esperion Therapeutics to commercialize NEXLETOL® and NEXLIZET® in Canada
May 8, 2025
·
6 min read
Press Releases
Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™
April 29, 2025
·
5 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
May 9, 2025
·
8 min read
Press Releases
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
April 17, 2025
·
13 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
April 28, 2025
·
5 min read
1 of 59,987
Next
